Mon.Aug 12, 2024

article thumbnail

What’s in a drink? U.S. regulators consider new alcohol label, but health advocates want even more

STAT

If you twirl a bottle of alcohol and squint, you might see a text box with a warning. Usually in black and white, with letters two to three millimeters high, it reads: GOVERNMENT WARNING: (1) According to the Surgeon General, women should not drink alcoholic beverages during pregnancy because of the risk of birth defects. (2) Consumption of alcoholic beverages impairs your ability to drive a car or operate machinery, and may cause health problems.

Labelling 362
article thumbnail

M&A is ready to explode, and that’s good news for pharma layoffs

PharmaVoice

Deals driven by obesity meds are fueling an M&A comeback.

230
230
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Opinion: The FDA should withdraw approval of more than 400 tainted medicines

STAT

When the FDA learned that a testing facility in India had submitted fraudulent data for more than 400 drugs (most of them generics), the agency should have withdrawn them from the market. Instead, it has allowed these drugs to continue to be prescribed and distributed for at least a year as the pharmaceutical companies retest them for equivalency to the original brand-name drugs.

article thumbnail

Following FDA rejection, a journal retracts papers on MDMA-assisted therapy

BioPharma Dive

Editors at Psychopharmacology cited "unethical conduct" that the study authors didn't disclose when submitting the papers. Lykos Therapeutics says it filed a complaint with a third party to review the way the journal came to its decision.

113
113
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Opinion: Some ‘inconvenient’ truths about pharmacy benefit managers

STAT

Pharmacy benefit managers have been in the crosshairs of late, as the focus of media scrutiny, government investigations and reports, and proposed federal legislation. A few recent examples make the point: A New York Times story in June 2024 bore the headline, “Pharmacy benefit managers are driving up drug costs for millions of people, employers and the government.

article thumbnail

Maintaining a Specialty Medication Regimen

Pharmaceutical Commerce

In this part of his Pharma Commerce video interview, Josh Marsh, Vice President and General Manager of Cardinal Health Sonexus Access and Patient Support, discusses the impact technology has in relation to patients sticking to their medication plan.

104
104

More Trending

article thumbnail

FDA approves Ascendis drug for rare endocrine condition

BioPharma Dive

The clearance of Yorvipath for hypoparathyroidism was some time coming for Ascendis, which had resubmitted after receiving a rejection last year.

113
113
article thumbnail

A tough week for MDMA-assisted psychotherapy

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Morning. A hard weekend for those backing MDMA-assisted psychotherapy: First, the FDA rejects a treatment from Lykos Therapeutics. Now a journal is retracting three MDMA papers, citing data integrity issues. Also, a nasal epinephrine spray gets an FDA approval, and more.

article thumbnail

Atul Bioscience receives US FDA EIR with zero observations for Ambernath facility

Express Pharma

Atul Bioscience, a 100 per cent subsidiary company of Atul, received Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) for its manufacturing facility situated in Ambernath, Maharashtra. The EIR was issued post the last inspection of the facility conducted from May 06, 2024, to May 10, 2024 which concluded with zero FDA 483 observations.

105
105
article thumbnail

Morning Rounds: Getting healthier in the checkout aisle and the alcohol aisle

STAT

Want to stay on top of health news?  Sign up  to get our Morning Rounds newsletter in your inbox. It’s Brittany subbing for Theresa this fine Monday. Thank you for all of the excellent song recommendations over the weekend. If you want to check out my road trip playlist, you can find it here.

276
276
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Pfizer builds case for RSV shot with data from immunocompromised adults

BioPharma Dive

Results from a Phase 3 study could help Pfizer broaden use of its vaccine Abrysvo to younger adults whose medical history puts them at higher risk.

Vaccines 109
article thumbnail

Novo Nordisk Education Foundation and RNT medical college to establish India’s first ‘Sickle Cell Wellness Hub’

Express Pharma

Novo Nordisk Education Foundation (NNEF), a non-profit organisation set up by Novo Nordisk India, signed a Memorandum of Understanding (MoU) with Rabindranath Tagore (RNT) Medical College, Udaipur to establish a ‘Sickle Cell Wellness Hub’ dedicated to people living with sickle cell disease (SCD). The MoU was signed between Dr Vipin Mathur – Principal & Controller, RNT Medical College and Vikrant Shrotriya – Managing Trustee, Novo Nordisk Education Foundation.

Hospitals 104
article thumbnail

Pfizer announces top-line results of ABRYSVO® for RSV in immunocompromised adults

World Pharma News

Pfizer Inc. (NYSE: PFE) today announced positive top-line safety and immunogenicity results from substudy B of the ongoing pivotal Phase 3 clinical trial ( NCT05842967) MONeT (RSV I Mmunizati ONStudy for Adul Ts at Higher Risk of Severe Illness), evaluating two doses of ABRYSVO vaccine in immunocompromised adults aged 18 and older at risk of developing severe respiratory syncytial virus (RSV)-associated lower respiratory tract disease (LRTD).

article thumbnail

Era of ADCs: Pharma companies innovate to stand out in a buzzing market

Pharmaceutical Technology

As antibody drug conjugate (ADC)-centred deals dominate the oncology space, biotechs are using newer targets and linkers to differentiate themselves.

105
105
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

The politics of health: How elections will impact life sciences

pharmaphorum

Explore how the recent and upcoming elections may impact the field of life sciences and medical technology. Stay informed about the intersection of politics and health advancements.

109
109
article thumbnail

Support DPPs with protected learning time, RPS urges

The Pharmacist

Prescribers must get the support they need to train, supervise and support trainees as designated prescribing practitioners (DPPs), the Royal Pharmaceutical Society (RPS) has urged. This comes as the RPS and the National Pharmacy Association (NPA) have together published a roundtable report discussing the barriers and solutions to providing prescribing training for pre-registration pharmacists.

89
article thumbnail

NICE updates on controversial multiple myeloma decisions

pharmaphorum

Three controversial decisions by NICE on NHS use of new multiple myeloma therapies are heading for the end of comment and appeals processes.

103
103
article thumbnail

PLAIO raises €4.3M to revolutionize pharma supply chains with AI-driven planning platform

Outsourcing Pharma

In a landmark move for the pharmaceutical industry, PLAIO, a pioneering Icelandic tech firm, has secured â4.3 million in an oversubscribed funding round to accelerate its AI-driven sales and operations planning platform designed specifically for the pharmaceutical sector.

86
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Study suggests COVID-19 vaccination lowers incidence of arterial thromboses

Pharma Times

A second dose of the vaccine lowered the incidence of conditions such as heart attack or stroke

Vaccines 112
article thumbnail

UKBPA welcomes single route to register internationally qualified pharmacists

The Pharmacist

The president of the UK Black Pharmacist Association (UKBPA) has welcomed the change in proposed training routes for internationally qualified pharmacists. This comes as the General Pharmaceutical Council (GPhC) has scrapped its proposals for a three-route system that had come under fire for potentially being unfair. Instead, the GPhC has now proposed a single, one-year […] The post UKBPA welcomes single route to register internationally qualified pharmacists appeared first on The Pharmaci

84
article thumbnail

UCL study reveals routine blood tests could improve early cancer diagnosis

Pharma Times

Bowel cancer was the most common cancer to be identified in both men and women

117
117
article thumbnail

Lykos’ heartache over FDA setback as new trial for groundbreaking PTSD treatment ordered

Outsourcing Pharma

In a blow to millions of Americans battling post-traumatic stress disorder (PTSD), Lykos Therapeutics announced today that the US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for its new drug application (NDA) for midomafetamine capsules.

80
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

MSD adds bispecific cancer antibody via $1.3bn Curon deal

pharmaphorum

MSD adds a bispecific antibody for blood cancers and autoimmune diseases to its pipeline via a $1.3bn licensing deal with Curon Biopharma.

107
107
article thumbnail

Pharmacy Deserts are Becoming a National Problem

Pharmaceutical Commerce

A lack of access could shut out patients in need of maintenance drugs for complex conditions.

104
104
article thumbnail

FDA clears first anaphylaxis nasal spray at second attempt

pharmaphorum

ARS Pharma gets FDA approval for epinephrine nasal spray neffy, the first needle-free alternative to EpiPen-style autoinjectors for serious allergic reactions.

99
article thumbnail

Every Day Counts for PTE: Court Finds FDA’s Reinterpretation of Testing Phase Arbitrary and Capricious

FDA Law Blog: Biosimilars

By Sara W. Koblitz — In the world of patent term extensions, every day considered part of the regulatory review period is important, as that day—either in whole or in part—gets added back to the patent upon approval of the product. In the veterinary world, where rolling applications are common, the testing phase is usually particularly important because the review phase, which starts only when the last component of the rolling New Animal Drug Application (NADA)—called the Administrative NADA—is

59
article thumbnail

Another AIM defection as BiVictriX plans to delist

pharmaphorum

BiVictriX is the latest UK biotech to say it wants to cancel its AIM-listed shares and go private in pursuit of better financing opportunities.

99
article thumbnail

MSD set to acquire novel antibody for B-cell malignancies

European Pharmaceutical Review

Merck (MSD outside of the US and Canada) has agreed to acquire a novel biologic for B-cell associated diseases, from the biotech Curon Biopharmaceutical. CN201 is a novel CD3xCD19-targeting T-cell-engager bispecific antibody. Through the agreement, Merck, through a subsidiary, will acquire worldwide rights, for a total of $700 million. Curon stated that it will be eligible for up to $600 million in milestone payments for CN201.

article thumbnail

Article retractions muddy MDMA waters after FDA denial

pharmaphorum

Journal retracts three articles on MDMA-assisted psychotherapy, shortly after FDA blocks approval of @Lykos_PBC's therapy for PTSD

103
103
article thumbnail

Sandoz’s Enzeevu secures FDA approval for nAMD treatment

Pharmaceutical Business Review

Enzeevu is designed to improve and maintain visual acuity in patients suffering from nAMD, a condition that is a primary cause of vision impairment among individuals over 50 years. Enzeevu’s active component is aflibercept. Aflibercept is a recombinant fusion protein that attaches to vascular endothelial growth factor A (VEGF-A) and placental growth factor (PlGF), preventing aberrant vessel development.

article thumbnail

Startup Halda raises $126M to advance new type of targeted cancer therapy

BioPharma Dive

Technology emerging from Yale researcher Craig Crews’ labs will be used to target prostate and breast cancer in early clinical trials.

67
article thumbnail

Pharma Pulse 8/12/24: Balancing Profitability and Mission, Minority Groups Remain Underrepresented in Vitiligo Trials & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

105
105